CAMDEN — A Zanesville, Ohio, woman is suing the makers and distributors of NuvaRing, citing alleged failure to warn of the harmful effects of NuvaRing.
Kasey Brownrigg filed a complaint in the U.S. District Court for the District of New Jersey against Organon USA, Inc., N.V. Organon, Schering Corp., Merck & Co. Inc. and Merck Sharp & Dohme, alleging that the defendants failed to properly disclose the known safety hazards associated with the contraceptive NuvaRing.
This is a potential tag-along action that should be transferred to the U.S. District Court for the Eastern District of Missouri to be included in a NuvaRing products liability case, according to court documents.
According to the complaint, the plaintiff alleges that on July 27, 2015, she began to experience chest pain and shortness of breath and was advised by a Genesis Healthcare physician to discontinue the use of the NuvaRing because a CT angiograph of her chest revealed a pulmonary embolism.
As a result, Brownrigg claims she suffered injuries and continues to receive follow-up care, including examinations, appointments and medications.
The plaintiff alleges the defendants failed to warn consumers of the serious risks of the product, failed to conduct appropriate testing prior to the NuvaRing being prescribed to consumers and failed to provide proper and full information as to the safety of the product to the U.S. Food and Drug Administration.
The plaintiff requests a trial by jury and seeks judgment in excess of $75,000 for all damages caused, expenses, costs of this action and such further relief as the court deems necessary, just and proper. She is represented by David B. Krangle and Andres F. Alonso of Alonso Krangle LLP in Melville, New York.
U.S. District Court for the District of New Jersey case number 4:17-cv-02152-RWS